Are localized prostate cancer biomarkers useful in the clinical practice?
Prostate cancer presents itself in a heterogeneous way with both aggressive and indolent forms. Despite the controversy surrounding its use, prostate-specific antigen screening ultimately leads to a greater number of diagnosed patients. One of the biggest challenges in clinical practice is to select...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2018-09-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428318799255 |